Cyient Limited has announced the grant of stock options to associates of the company and its subsidiaries on 23 April 2026. The Leadership, Nomination and Remuneration Committee has approved the allocation of 1,85,000 stock options under two existing employee stock option schemes.

Stock Option Grant Details

The committee has distributed the stock options across two employee stock option plans as part of the company's ongoing employee incentivization strategy.

The ASOP 2023 plan received the larger allocation with 1,07,000 options, while the ARSU 2020 plan was allocated 78,000 options. This distribution indicates the company's focus on utilizing its newer stock option framework while maintaining continuity with existing plans.

Employee Stock Option Programs

The grant covers associates from both Cyient Limited and its subsidiaries, demonstrating the company's comprehensive approach to employee equity participation across its organizational structure. The ARSU 2020 and ASOP 2023 plans represent the company's structured employee stock option schemes designed to align employee interests with shareholder value creation.

Corporate Governance

The stock option grant was formally communicated to both BSE Limited and National Stock Exchange of India Limited on 23 April 2026, ensuring compliance with regulatory disclosure requirements. The decision was executed by the Leadership, Nomination and Remuneration Committee, reflecting proper corporate governance practices in employee compensation matters.

This stock option allocation reinforces Cyient's commitment to employee retention and motivation through equity-based compensation, providing associates with opportunities to participate in the company's long-term growth and success.

Cyient Limited has announced that its Board of Directors will convene on April 23, 2026, to deliberate on several critical corporate matters, including the approval of audited financial results for the quarter and year ended March 31, 2026. The meeting notification was issued on April 14, 2026, in compliance with Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Agenda Items

The board meeting will address multiple significant corporate decisions that could impact shareholders and the company's financial structure:

Financial Results and Reporting

The board will approve and take on record the audited financial results prepared under Indian Accounting Standards (Ind AS) for both standalone and consolidated entities. The standalone results will cover Cyient Limited's performance, while the consolidated results will encompass the company and its subsidiaries for the quarter and year ended March 31, 2026.

Dividend and Capital Structure Decisions

Shareholders will be particularly interested in the board's deliberation on the final dividend recommendation for the financial year ended March 31, 2026. Additionally, the board will consider and approve a proposal for the buyback of equity shares, which requires obtaining necessary statutory and regulatory approvals before implementation.

Regulatory Compliance

The meeting intimation was signed by Ravi Kumar Nukala, Deputy Company Secretary, ensuring proper corporate governance protocols. The company has provided advance notice to both BSE Limited and National Stock Exchange of India Limited, maintaining transparency with stock exchanges and regulatory bodies.

Investors and stakeholders will await the outcomes of this board meeting, particularly regarding the financial performance metrics, dividend declarations, and the specifics of any proposed share buyback program that may be announced following the April 23, 2026 session.